Chronic wasting disease (CWD) is a prion disease of cervids characterized by clinical symptoms of progressive weight loss, abnormal behaviour and excessive salivation. Incidents have been reported in North America and Korea as well as in Europe. Current knowledge, based on in vitro and in vivo experiments, suggests direct CWD transmission to humans is unlikely. Nonetheless, humans may consume CWD-infected materials, which presents a potential risk. Studies indicate that transmission by horizontal infection of cervids probably occurs via saliva, faeces, and urine as well as from environmental reservoirs of prions found in soil and water. In addition, infectivity in the skeletal muscle of infected deer has been observed. These findings suggest that direct contact with infected animals and indirect contact with prion-contaminated materials are potential sources of infection. However, recent studies on the detection of pregnancy-related prion infectivity imply the potential transmission of CWD from mother to offspring. In this review, fundamental aspects of CWD are reviewed.
Clinical symptoms and pathogenesis of CWD
The characteristic clinical symptoms of CWD-infected animals are slow progressive neurological dysfunction, weight loss, behavioural changes, emaciation, excessive salivation, teeth grinding, fever, anorexia, polyposia, dysphagia, excessive urination, impaired motor coordination and respiratory distress (Sohn et al., 2002; Williams, 2005; Haley et al., 2015) . Because these symptoms are not CWD-specific, additional biochemical and pathological analysis is required to verify the diagnosis. Although CWD-infected deer displaying symptoms of the disease can be found throughout the year, infected carcasses are most common in the winter period. The relative profusion of infected carcasses at this time of the year is probably due to the severe winter climate in North America. Furthermore, most deer displaying symptoms of CWD are three to four years of age.
After infection with CWD agent, cellular PrP (PrP C ) is converted into PrP CWD , which accumulates in brain tissue causing neurological symptoms and ultimately death. PrP CWD is primarily distributed in the central nervous system (CNS) and lymphatic tissues, including brain, spinal cord, tonsil, lymph node and spleen. Small quantities of PrP CWD agent are also found in the heart and eyes of infected deer. In addition, deboned muscle (Angers et al., 2006) and fat (Race et al., 2009) as well as antler velvet (Angers et al., 2009 ) have proven to be infectious. Prion infectivity was found in the pregnancy microenvironment of cervids, including the uterus, placenta, ovary, and the placentome (Nalls et al., 2017 (Nalls et al., , 2018 . Importantly, CWD prions have been detected in body fluids and excreta such as saliva (Haley et al., 2009a ), urine (Haley et al., 2009a , faeces (Tamgüney et al., 2009) , amniotic fluid (Nalls et al., 2017) , cerebrospinal fluid (Nichols et al., 2012) and blood (Mathiason et al., 2006) (Table 9 .1), which may be an important source of infection.
Orally infected CWD-brain homogenate of mule deer induces PrP CWD accumulation as early as 42 days post infection in intestine-associated lymphatic tissues, such as retropharyngeal lymph nodes, tonsil, Peyer's patch and ileocecal lymph nodes. Therefore, it has been proposed that CWD agent may be transmitted via clinical and pre-clinical animal carcasses as well as from by-products of deer, such as saliva, stools and urine (Miller et al., 2004; Mathiason et al., 2006; Haley et al., 2009a; Tamgüney et al., 2009 ). More importantly, (Angers et al., 2006) . This finding indicates that muscle is a potential source of infection, suggesting that the meat of deer must be treated with caution. At this time it remains unclear how CWD is spread. Natural or anthropogenic movement of animals may play an important role in the dissemination of CWD. Direct contact between animals and indirect transmission via soil and body surfaces are potential mechanisms for the spread of the disease. CWD is thought to be horizontally infected at a high rate among cervids (Miller et al., 2003) . Oral transmission of CWD-infected brain homogenate derived from mule deer to elk has been reported, which is further supported by the finding of CWD-infected free-ranging moose (Baeten et al., 2007) . Transfer of infectious material in saliva and/or stools is currently considered a likely means of transmission. The movement of animal carcasses also seems to be involved in the dispersion of CWD. This proposal is supported by evidence that an infected carcass placed in a field resulted in the transmission of CWD to experimental mule deer (Miller et al., 2004) , suggesting the spread of CWD may result from a contaminated CWD environment. Recent research has detected the peripheral accumulation of prions and the shedding of infectious prions in bodily fluids, which can be detected even before the appearance of clinical signs (Haley et al., 2017) . These findings suggest that not only clinical but also preclinical animals as well as carcasses and by-products may contribute to the transmission and spread of CWD. There is also evidence for the horizontal transmission of CWD based on epidemiological data as well as experimental model studies using transgenic mice expressing the normal cervid prion protein (Seelig et al., 2010) .
CWD strains
Currently, the number of CWD strains and their prevalence, as well as transmission properties, remain unclear. Recent studies indicate the presence of conformational variants or strains of CWD prions may exist. Indeed, sequential passage of a single mule deer CWD isolate using hamster or hamster-PrP expressing transgenic mice causes two distinct disease phenotypes (Raymond et al., 2007; Heisey et al., 2010) . Moreover, LaFauci et al. (2006) have reported that elk PrP-expressing transgenic mice developed phenotypically divergent diseases when inoculated with either mule deer or elk CWD, which was suggestive of different strains among cervids. These studies, together with other bioassay data, suggest the presence of predominant strain types comprising at least two, and possibly three, distinct CWD strains in North America (e.g. CWD1 and CWD2; Sgha CWDmd-f and Sgha CWDmd-s; CWD-WI and CWD-CSU; WST and CKY) (Raymond et al., 2007; Angers et al., 2010; Bessen et al., 2011; Perrott et al., 2012; Crowell et al., 2015; Triscott et al., 2015; EFSA, 2017) . However, the newly discovered CWD prion in Norway seems to be different from the above-mentioned CWD prion strains (Bian et al., 2018) .
Relationship between CWD and human prion diseases
Several animal prion diseases, such as scrapie, bovine spongiform encephalopathy (BSE), transmissible mink encephalopathy, feline spongiform encephalopathy, and ungulate spongiform encephalopathy, display similar symptoms to CWD. However, there is no known relationship between CWD and these animal prion diseases. In addition, epidemiological studies showed no correlation between CWD and human prion diseases (Belay et al., 2004; Anderson et al., 2007; Oszowy et al., 2014; Haley et al., 2015) . Most laboratory studies also suggest that the risk of CWD transmission to humans is low. This conclusion is supported by a study in which intracerebral inoculation of CWD prions to transgenic mice expressing human PrP did not lead to the development of any hallmark symptoms of CWD after > 650 days, while an equivalent inoculation to transgenic mice expressing cervid PrP resulted in infection within 150 days (Kong et al., 2005) . These findings indicate the presence of a barrier that makes interspecies transmission unlikely, especially between species as diverse as humans and deer (Kong et al., 2005) . Moreover, an in vitro assay showed PrP CWD mediated conversion of human PrP to a protease-resistant form is very inefficient, suggesting a species barrier at the molecular level that limits the susceptibility of humans to CWD (Raymond et al., 2000) .
In marked contrast, transmission experiments involving non-human primates have shown mixed results. For example, squirrel monkeys were found to be susceptible to CWD infection (Race et al., 2014) , although there was no clinical, pathological, or biochemical evidence of CWD transmission to cynomolgus macaques (Race et al., 2018) . Currently, it is unclear why cynomolgus macaques and squirrel monkeys give markedly different results with regard to CWD transmission. Although the conclusions to be drawn from studies using non-human primates as infection models are still a matter of debate, a plethora of laboratory experiments suggest the risk of CWD transmission to humans is low (Hannaoui et al., 2017) . Nonetheless, the potential zoonotic transmission of CWD is an alarming prospect. Given that the scientific information on CWD is limited, consumption of CWD-positive animals should be prohibited at this time.
Diagnostic methods for CWD
The gold standard of CWD diagnosis is immunohistochemistry (IHC) (Haley et al., 2017) . Medullary obex and lymphatic tissues, such as tonsil and pharyngeal lymph nodes, are used for this analysis. Dorsal motor nucleus of the vagus (DMNV) in the obex region of the brainstem and the medial retropharyngeal lymph nodes (RLN) is generally used for regulatory diagnosis (Sigurdson et al., 1999; Peters et al., 2000; Keane et al., 2008a) . IHC is a method of observing tissue sections stained with anti-PrP antibody using light microscopy. This methodology has merits in terms of its high level of sensitivity and specificity. In addition, IHC can be used to verify whether the tissue distribution of PrP CWD is as anticipated. Other methods for CWD diagnosis include enzyme-linked immunosorbent assay (ELISA) and western blotting. ELISA is used to detect PrP adsorbed on plates after treatment of brain homogenate with PK. Western blotting detects PrP absorbed on a membrane after an electroblotting procedure. ELISA is preferable because the technique allows rapid and quantitative analysis. However, western blotting facilitates more detailed biochemical analysis such as determination of the molecular weight of PrP. Such information may be used to help identify the prion source and specific strain.
The United States Department of Agriculture (USDA) has recently certified an ELISA kit as an official screening test for CWD using obex and lymph node tissues (USDA, 2017). Further developments in detecting CWD have enabled antemortem diagnosis using IHC of tonsil tissue. In addition, a method for prion diagnosis, known as PMCA, has been developed that amplifies PK-resistant PrP by sequential incubation and sonication using a mixture of PrP C source and PrP CWD seed. PMCA can detect PrP CWD in the urine of presymptomatic deer (Rubenstein et al., 2011) and the blood of asymptomatic deer (Kramm et al., 2017) .
More recently, a real-time quaking-induced conversion (RT-QuIC) assay, which is a modified version of PMCA for enabling the quantification of PrP CWD at high sensitivity, has been developed (Manne et al., 2017) . Using this methodology it is possible to perform antemortem detection of CWD in recto-anal mucosa-associated lymphoid tissue (RAMALT). The performance of RT-QuIC showed good results at 92% relative sensitivity and 95% relative specificity using blinded samples compared to IHC results. Other researchers also detected PrP CWD from RAMALT and nasal brushings using RT-QuIC (Haley et al., 2016) .
Powerful research tools to analyse CWD will be invaluable in helping to reveal the molecular basis of the disease. For example, a transgenic mouse expressing cervid PrP (Browning et al., 2004; Seelig et al., 2010) and a CWD-susceptible cell line (Raymond et al., 2006) have been developed. Such tools will be used to devise bioassays of CWD infectivity in tissues and body fluids derived from CWD-infected cervids.
Taken together, the recent development of diagnostic technologies, such as qualitative and quantitative amplification techniques, enables not only postmortem but also antemortem detection of PrP CWD from peripheral tissues and body fluids. In addition, these diagnostic methods will contribute to further risk assessment of deer tissues and body fluids obtained from CWD-endemic areas as well as improving surveillance programs.
Conclusion and perspectives
There is a strikingly high incidence of CWD in wild animals, such as deer and elk, which maintains a reservoir of CWD prions that is difficult to counteract by the simple approach of targeted culling. In addition, the high stability of CWD prions in the environment further exacerbates the problem. Moreover, the diverse distribution of CWD prions within the body of infected cervids, including neurological and peripheral tissues as well as muscle, fat and pregnancy tissues, increases the chances of transmitting the disease. In particular, the presence of CWD prions in body fluids, such as saliva, faeces and urine, enhances infectivity and may lead to both horizontal and vertical transmission. Although more than two CWD strains have been found, their host range and prevalence as well as transmission features remain unclear at the present time.
To date, laboratory studies and epidemiological investigations suggest little association between human prion diseases and exposure to CWD prions. However, it is not known whether there is an absolute species barrier for humans against all strains of CWD prions. Thus, long-term investigations to study potential human infection and exposure to CWD prions are needed.
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